Shares of communications testing firm Viavi Solutions surged over 17% to a level not seen since 2002, as investors cheered a new restructuring initiative aimed at saving $30 million annually, despite the company posting a quarterly net loss.
Despite reporting a near-doubling of annual net income and raising its 2026 outlook, electronics manufacturer Celestica saw its shares drop sharply Thursday as the market judged its stellar results to be already reflected in the price.
Despite a challenging housing market, Five Point Holdings (NYSE:FPH) reported record annual net income for 2025, driven by strategic land sales and the integration of its Hearthstone platform. The company navigated economic uncertainty with disciplined pricing and secured major entitlement approvals to fuel its long-term pipeline.
The Swedish industrial giant reported lower sales and net income for 2025 but proposed maintaining its ordinary dividend and adding a special distribution, a move analysts interpret as a show of financial strength despite near-term headwinds.
Celestica's Q4 2025 results shattered guidance, fueled by its Connectivity & Cloud unit. The company announces a massive capital expenditure surge to over $1 billion in 2026, betting big on sustained demand from hyperscalers for AI and networking infrastructure.
Axos Financial (NYSE: AX) reported strong fiscal Q2 2026 results, with net income jumping to $128.4 million. Driven by broad-based loan growth and contributions from Verdant Commercial Capital, the digital bank highlighted expanding margins, improved credit metrics, and a confident outlook for continued mid-teens annual loan growth.
Shares of Viavi Solutions soared over 17% after the network test and measurement company posted fiscal Q2 results that smashed analyst expectations, fueled by robust demand from data center and aerospace clients.
Gold prices have shattered records, breaching $5,000 per ounce as geopolitical tensions and shifting monetary policies drive a historic rally. Analysts debate whether this is a peak or a new foundation for the safe-haven asset.
Cardinal Health (CAH) stock has drawn renewed investor interest following robust financial results, with revenue topping $234 billion and net income near $1.6 billion. The healthcare distributor's shares have rallied over 66% in the past year, though its premium valuation compared to peers is sparking debate among analysts.
Facing uneven long-term performance, UPS announces a major strategic overhaul involving significant job reductions, facility closures, and a deliberate move away from low-margin Amazon volume. The company is betting big on healthcare logistics through acquisitions to bolster its global cold chain network.
LPL Financial reported record quarterly and annual earnings, driven by robust organic growth and strategic acquisitions. Executives detailed progress on integrating Commonwealth Financial Network and provided updated guidance, signaling confidence in sustained momentum despite market headwinds.
Aon plc (NYSE: AON) is in the spotlight following the launch of a major emerging markets climate transition fund with Irish Life Investment Managers. The move expands its sustainable investment footprint to over €1 billion as analysts scrutinize whether its current share price fully reflects future growth prospects amid a mixed performance backdrop.
NewtekOne (NASDAQ: NEWT) reported robust Q4 and full-year 2025 results, highlighting the third anniversary of its OCC-chartered bank. The financial holding company saw net income rise 16.4% to $80 million, driven by strong deposit growth, successful securitizations, and a focus on serving independent business owners with long-term, 'patient capital' loans.
MINISO Group Holding Ltd. (NYSE: MNSO) is capturing investor attention with a potent mix of rapid global store expansion, surging revenue from its TOP TOY brand, and robust cash generation. The company's latest earnings reveal a strategic pivot paying off, even as it navigates the competitive global retail landscape.
A sophisticated, high-conviction options trade by a large investor signals strong confidence in Edwards Lifesciences' fundamentals, with a potential breakout eyed for early 2026 tied to regulatory milestones and sustained growth in its mitral valve business.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
Despite facing near-term pressures from a softer ad market and intensified competition, The Trade Desk's leadership in programmatic advertising and its scalable platform present a compelling case for patient investors eyeing the sector's structural shift.
Cronos Group's stock has rallied on renewed optimism for U.S. cannabis reform. We examine the regulatory shift, strategic positioning, and long-term potential driving investor sentiment.
Amidst market volatility, EVERTEC Inc. (EVTC) presents a compelling investment case. Trading at depressed valuation multiples, the Latin American transaction processing leader combines a 'boring but consistent' operational profile with significant potential for multiple expansion and steady growth, offering a unique risk/reward balance for patient investors.
Amid market volatility, Mettler-Toledo International Inc. (MTD) continues to draw bullish attention for its entrenched role in mission-critical measurement technology across life sciences and industrial sectors. Analysts argue its premium valuation reflects durable competitive advantages rather than market froth.
